Pediatric Epiglottitis Medication

  • Author: Robert W Tolan Jr, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Jun 6, 2011
 

Medication Summary

Antibiotic therapy is necessary in the management of epiglottitis but should be initiated after the airway is secured. Before obtaining culture results, use antibiotics for the most likely organisms. Following trauma to the epiglottis, Staphylococcus aureus should be suspected. With the presence of white patches, Candida albicans should be suspected. Sedation for comfort is also required.

Next

Antibiotic agents

Class Summary

Initiate antibiotics to provide empiric coverage of the most likely bacterial pathogens in the context of the clinical setting. Treatment should continue for 7-10 days, in general.

Ceftriaxone (Rocephin)

 

Ceftriaxone is a third-generation cephalosporin antibiotic with broad-spectrum activity against gram-negative bacteria, including Haemophilus influenzae, Enterobacteriaceae, and Neisseria species, and variable activity against gram-positive bacteria. This agent binds to penicillin-binding proteins and inhibits the final transpeptidation step of peptidoglycan synthesis, resulting in cell wall destruction and death of the organism.

Cefotaxime (Claforan)

 

Cefotaxime is another third-generation cephalosporin antibiotic with broad-spectrum activity against gram-positive and gram-negative bacteria. This agent binds to penicillin-binding proteins and inhibits the final transpeptidation step of peptidoglycan synthesis, resulting in cell wall destruction and death of the organism.

Cefuroxime (Zinacef , Kefurox)

 

Cefuroxime is a second-generation cephalosporin antibiotic with activity against gram-positive and some gram-negative bacteria, including Haemophilus influenzae. Cefuroxime binds to penicillin-binding proteins and inhibits the final transpeptidation step of peptidoglycan synthesis, resulting in cell wall destruction and death of the organism.

Chloramphenicol

 

When combined with ampicillin, chloramphenicol is an alternative agent if cephalosporins are unable to be used. This agent elicits activity against some gram-positive, gram-negative, and anaerobic organisms by inhibiting protein synthesis via reversibly binding to the 50S ribosomal subunit. Although unavailable in the United States, this antibiotic remains in use in parts of the world.

Clindamycin (Cleocin)

 

Clindamycin is a semisynthetic antibiotic produced by the 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compound, lincomycin. It is useful for gram-positive infections, including most community-associated MRSA disease. This agent inhibits bacterial growth, possibly by blocking dissociation of peptidyl tRNA from ribosomes, causing RNA-dependent protein synthesis to arrest. Clindamycin widely distributes in the body without penetration of the central nervous system. This drug is protein bound and excreted by the liver and kidneys.

Ampicillin and sulbactam (Unasyn)

 

Ampicillin with sulbactam is the drug combination of a beta-lactamase inhibitor with ampicillin. This combination interferes with bacterial cell wall synthesis during active replication, causing bactericidal activity against susceptible organisms.

Ampicillin with sulbactam is used as an alternative to amoxicillin when the patient is unable to take medication orally. This combination covers skin, enteric flora, and anaerobes but is not ideal for nosocomial pathogens.

Rifampin (Rifadin)

 

Rifampin is used for chemoprophylaxis in Hib infections.

Previous
Next

Analgesic-Antipyretics

Class Summary

Analgesic-antipyretic agents are helpful in relieving the lethargy, malaise, and fever associated with epiglottitis.

Acetaminophen (Tylenol, Acephen, Aspirin-Free Anacin)

 

Acetaminophen is the drug of choice (DOC) for treating pain in patients with documented hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs), those with upper gastrointestinal disease, or those who take oral anticoagulants. This agent reduces fever by a direct action on the hypothalamic heat-regulating centers, which increases dissipation of body heat via vasodilation and sweating.

Ibuprofen (NeoProfen, Advil, Motrin)

 

Ibuprofen is usually the DOC for treating mild to moderate pain, if no contraindications exist. This agent inhibits inflammatory reactions and pain, probably by decreasing the activity of the cyclooxygenase enzyme, which inhibits prostaglandin synthesis. Ibuprofen is one of the few nonsteroidal anti-inflammatory drugs (NSAIDs) indicated for fever reduction.

Previous
Next

Vaccines, Inactivated (Bacterial)

Class Summary

These agents are used to induce active immunization against Haemophilus influenza type b.

Haemophilus b conjugate vaccine (ActHIB, Hiberix, PedvaxHIB)

 

This vaccine is used for routine immunization of children against invasive diseases caused by H influenzae type b by decreasing nasopharyngeal colonization. The CDC's Advisory Committee on Immunization Practices (ACIP) recommends that all children receive one of the conjugate vaccines licensed for infant use beginning routinely at age 2 months.

Previous
 
Contributor Information and Disclosures
Author

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: GlaxoSmithKline Honoraria Speaking and teaching; MedImmune Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Sanofi Pasteur Honoraria Speaking and teaching; Baxter Healthcare Honoraria Speaking and teaching; Novartis Honoraria Speaking and teaching

Coauthor(s)

Antonio Muñiz, MD  Professor of Emergency Medicine and Pediatrics, University of Texas Medical School at Houston; Medical Director of the Pediatric Emergency Department, Children's Memorial Hermann Hospital

Antonio Muñiz, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Pediatrics, American College of Emergency Physicians, American Heart Association, American Medical Association, Society for Academic Emergency Medicine, and Southern Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Ashir Kumar, MD, MB  Professor Emeritus, Department of Pediatrics and Human Development, Michigan State University College of Human Medicine

Ashir Kumar, MD, MB is a member of the following medical societies: American Association of Physicians of Indian Origin and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD  Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References
  1. Kamienski M. When sore throat gets serious: three different cases, three very different causes. Am J Nurs. Oct 2007;107(10):35-8. [Medline].

  2. Tebruegge M, Connell T, Kong K, Marks M, Curtis N. Necrotizing epiglottitis in an infant: an unusual first presentation of human immunodeficiency virus infection. Pediatr Infect Dis J. Feb 2009;28(2):164-6. [Medline].

  3. Kong MS, Engel SH, Zalzal GH, Preciado D. Necrotizing epiglottitis and hemophagocytic lymphohistiocytosis. Int J Pediatr Otorhinolaryngol. Jan 2009;73(1):119-25. [Medline].

  4. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. Jan 13 1993;269(2):221-6. [Medline].

  5. Frantz TD, Rasgon BM. Acute epiglottitis: changing epidemiologic patterns. Otolaryngol Head Neck Surg. Sep 1993;109(3 Pt 1):457-60. [Medline].

  6. Faden H. The dramatic change in the epidemiology of pediatric epiglottitis. Pediatr Emerg Care. Jun 2006;22(6):443-4. [Medline].

  7. Hopkins A, Lahiri T, Salerno R, Heath B. Changing epidemiology of life-threatening upper airway infections: the reemergence of bacterial tracheitis. Pediatrics. Oct 2006;118(4):1418-21. [Medline].

  8. Guldfred LA, Lyhne D, Becker BC. Acute epiglottitis: epidemiology, clinical presentation, management and outcome. J Laryngol Otol. Aug 2008;122(8):818-23. [Medline].

  9. Devlin B, Golchin K, Adair R. Paediatric airway emergencies in Northern Ireland, 1990-2003. J Laryngol Otol. Jul 2007;121(7):659-63. [Medline].

  10. Kavanagh KR, Batti JS. Traumatic epiglottitis after foreign body ingestion. Int J Pediatr Otorhinolaryngol. Jun 2008;72(6):901-3. [Medline].

  11. Ehara H. Tenderness over the hyoid bone can indicate epiglottitis in adults. J Am Board Fam Med. Sep-Oct 2006;19(5):517-20. [Medline].

  12. Sobol SE, Zapata S. Epiglottitis and croup. Otolaryngol Clin North Am. Jun 2008;41(3):551-66, ix. [Medline].

  13. Glynn F, Fenton JE. Diagnosis and management of supraglottitis (epiglottitis). Curr Infect Dis Rep. May 2008;10(3):200-4. [Medline].

  14. [Medline].

  15. Acevedo JL, Lander L, Choi S, Shah RK. Airway management in pediatric epiglottitis: a national perspective. Otolaryngol Head Neck Surg. Apr 2009;140(4):548-51. [Medline].

  16. Alcaide ML, Bisno AL. Pharyngitis and epiglottitis. Infect Dis Clin North Am. Jun 2007;21(2):449-69, vii. [Medline].

  17. Briem B, Thorvardsson O, Petersen H. Acute epiglottitis in Iceland 1983-2005. Auris Nasus Larynx. May 22 2008;[Medline].

  18. Chiou CC, Seibel NL, Derito FA, Bulas D, Walsh TJ, Groll AH. Concomitant Candida epiglottitis and disseminated Varicella zoster virus infection associated with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. Nov 2006;28(11):757-9. [Medline].

  19. D'Agostino J. Pediatric airway nightmares. Emerg Med Clin North Am. Feb 2010;28(1):119-26. [Medline].

  20. Duval M, Daniel SJ. Guillain-Barre syndrome presenting as epiglottitis in a child. Otolaryngol Head Neck Surg. Apr 2010;142(4):632-3. [Medline].

  21. Jenkins IA, Saunders M. Infections of the airway. Paediatr Anaesth. Jul 2009;19 Suppl 1:118-30. [Medline].

  22. Katori H, Tsukuda M. Acute epiglottitis: analysis of factors associated with airway intervention. J Laryngol Otol. Dec 2005;119(12):967-72. [Medline].

  23. Martin S, Waters K, Perez MK, Kleman BT, Nield LS. Index of suspicion. Pediatr Rev. Mar 2009;30(3):107-13. [Medline].

  24. Murphy TV, White KE, Pastor P, et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA. Jan 13 1993;269(2):246-8. [Medline].

  25. Nozicka CA, Naidu SH, McFadden J. Varicella-associated acute supraglottitis. Ann Emerg Med. Apr 1994;23(4):888-90. [Medline].

  26. Rogers DJ, Sie KC, Manning SC. Epiglottitis due to nontypeable Haemophilus influenzae in a vaccinated child. Int J Pediatr Otorhinolaryngol. Feb 2010;74(2):218-20. [Medline].

  27. Shah RK, Stocks C. Epiglottitis in the United States: national trends, variances, prognosis, and management. Laryngoscope. Jun 2010;120(6):1256-62. [Medline].

  28. Shah S, Sharieff GQ. Pediatric respiratory infections. Emerg Med Clin North Am. Nov 2007;25(4):961-79, vi. [Medline].

Previous
Next
 
Swollen epiglottis with characteristic thumbprint sign.
Comparison of a normal pediatric airway (bottom) and airway from a child who died from epiglottitis (top).
Child assuming the sniffing position with upper airway obstruction.
Swollen epiglottis with characteristic thumbprint sign.
Radiograph of a child with acute epiglottitis; note the hypopharyngeal dilatation, obliteration of the vallecula, and thickened aryepiglottic folds—a positive thumb sign.
Correct positioning for a cricothyroid needle insertion
Child with acute epiglottitis after intubation. Note cherry red epiglottis. This image was taken in 2008 and the child was completely immunized and grew HiB from surface culture.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.